Search
CONGRESS 2023 - Bench to Bedside: Clinical Cases from an HSST
26/09/2023
Bench to Bedside: Clinical Cases from an HSST
CONGRESS 2023 - Defining biomedical scientists in the NHS Long Term Workforce Plan - the IBMS plan
26/09/2023
Defining biomedical scientists in the NHS Long Term Workforce Plan - the IBMS plan
CONGRESS 2023 - Eco-epidemiology of tick-borne encephalitis virus in the UK
26/09/2023
Eco-epidemiology of tick-borne encephalitis virus in the UK
CONGRESS 2023 - Emerging arthropod-borne viral threats to the UK
26/09/2023
Globally, arthropod-borne viral diseases represent one the of greatest threats to public and animal health. Vectors such as mosquitoes, ticks and midges transmit a vast range of viruses. For the UK, historically free of many arthropod-borne pathogens, events in mainland Europe have had a profound impact on the risk of disease emergence and this trend will continue. Mosquito-borne viruses provide an example of this process where the introduction of exotic species, such as the Asian tiger mosquito (Aedes albopictus) across much of Europe, has increased the risk of emergence of human pathogens such as dengue and chikungunya fever. This mosquito species has also been detected in southern England.
In recent decades there has been a dramatic increase in the distribution of zoonotic viruses such as West Nile and Usutu in mainland Europe that are making the introduction of these pathogens through short distance bird migration increasingly likely. This has been realised with the repeated detection of Usutu virus in Central London during the late summer months since 2020. In the absence of vaccines against many of these viruses, early detection linked to public awareness campaigns offer the best options for mitigating the impact of these threats.
In recent decades there has been a dramatic increase in the distribution of zoonotic viruses such as West Nile and Usutu in mainland Europe that are making the introduction of these pathogens through short distance bird migration increasingly likely. This has been realised with the repeated detection of Usutu virus in Central London during the late summer months since 2020. In the absence of vaccines against many of these viruses, early detection linked to public awareness campaigns offer the best options for mitigating the impact of these threats.
CONGRESS 2023 - Expanding your role into Point-of-Care Testing – a career opportunity to consider
26/09/2023
Expanding your role into Point-of-Care Testing – a career opportunity to consider
CONGRESS 2023 - Highlighting the value of diagnostics, promoting the diagnostic workforce and improving diagnostic services
26/09/2023
Highlighting the value of diagnostics, promoting the diagnostic workforce and improving diagnostic services
CONGRESS 2023 - Highlights from the 2022 Annual SHOT Report: lessons learnt and learning from excellence
26/09/2023
Highlights from the 2022 Annual SHOT Report: lessons learnt and learning from excellence
CONGRESS 2023 - HSD in Immunology – A case study (Multiple Myeloma)
28/09/2023
This presentation will cover a case study completed as part of the IBMS Specialist Diploma in Immunology in 2022. It will be of interest to anyone considering completing the Higher Specialist Diploma in Immunology, or anyone who would like to learn more about the case study element. It will also be of interest to anyone who would like to learn more about the protocols used for reading and reporting methods including immunophenotyping by flow cytometry, serum protein electrophoresis and immunotyping, serum free light chains and Bence Jones protein analysis at Greater Manchester Immunology Service (GMIS).
The case is one of an elderly gentleman with who, like roughly a third of new myeloma cases in the UK, presented through A&E. The presentation will cover pre-analysis, analysis and post-analysis, considering how the tests performed in the Immunology laboratory assist in the differential diagnosis and where they fit in with the other tests ordered, both tests within and outside of the Immunology discipline. The presentation will cover the methods performed at GMIS and some of the reporting protocols, as well as discussing some of the relevant associated guidelines.
The case is one of an elderly gentleman with who, like roughly a third of new myeloma cases in the UK, presented through A&E. The presentation will cover pre-analysis, analysis and post-analysis, considering how the tests performed in the Immunology laboratory assist in the differential diagnosis and where they fit in with the other tests ordered, both tests within and outside of the Immunology discipline. The presentation will cover the methods performed at GMIS and some of the reporting protocols, as well as discussing some of the relevant associated guidelines.